Fate Therapeutics
FATE
#9130
Rank
ยฃ67.15 M
Marketcap
ยฃ0.59
Share price
-4.18%
Change (1 day)
-89.62%
Change (1 year)

P/S ratio for Fate Therapeutics (FATE)

P/S ratio as of April 2025 (TTM): 6.37

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.2722. At the end of 2024 the company had a P/S ratio of 13.5.

P/S ratio history for Fate Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202413.5131.76%
20235.80-42.99%
202210.2-89.82%
2021100-60.36%
202025281.87%
2019139-20.75%
2018175123.55%
201778.3231.94%
201623.6-40.72%
201539.8
2014N/A-100%
2013132

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.16-50.38%๐Ÿ‡บ๐Ÿ‡ธ USA
3.14-50.60%๐Ÿ‡บ๐Ÿ‡ธ USA
4.56-28.43%๐Ÿ‡บ๐Ÿ‡ธ USA
295 4,534.51%๐Ÿ‡บ๐Ÿ‡ธ USA
4.53-28.84%๐Ÿ‡บ๐Ÿ‡ธ USA